Radcliffe Capital Management’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,333
| Closed | -$1.21K | – | 684 |
|
|
2023
Q1 | $1.21K | Hold |
33,333
| – | – | ﹤0.01% | 683 |
|
|
2022
Q4 | $333K | Hold |
33,333
| – | – | 0.01% | 803 |
|
|
2022
Q3 | $334K | Hold |
33,333
| – | – | 0.01% | 1102 |
|
|
2022
Q2 | $330K | Hold |
33,333
| – | – | 0.01% | 1156 |
|
|
2022
Q1 | $329K | Hold |
33,333
| – | – | 0.01% | 1153 |
|
|
2021
Q4 | $325K | Hold |
33,333
| – | – | 0.01% | 1001 |
|
|
2021
Q3 | $326K | Hold |
33,333
| – | – | 0.01% | 853 |
|
|
2021
Q2 | $328K | Hold |
33,333
| – | – | 0.01% | 877 |
|
|
2021
Q1 | $333K | Buy |
+33,333
| New | +$333K | 0.01% | 663 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 300 |
|